Results 81 to 90 of about 48,475 (224)
Synaptic accumulation of FUS triggers age-dependent misregulation of inhibitory synapses in ALS-FUS mice [PDF]
FUS is a primarily nuclear RNA-binding protein with important roles in RNA processing and transport. FUS mutations disrupting its nuclear localization characterize a subset of amyotrophic lateral sclerosis (ALS-FUS) patients, through an unidentified ...
Pérez-Berlanga, Manuela +10 more
core +1 more source
Aims Spindle‐cell/sclerosing rhabdomyosarcomas (SS‐RMS) are clinically and genetically heterogeneous. They include three well‐defined molecular subtypes, of which those with EWSR1/FUS::TFCP2 rearrangements were described only recently. This study aimed to evaluate five new cases of SS‐RMS and to perform a clinicopathological and statistical analysis of
Martina Bradová +13 more
wiley +1 more source
The multifunctional FUS protein: Characterization of the biological effects of its depletion [PDF]
FUS/TLS (fused in sarcoma/translocated in liposarcoma) protein, a ubiquitously expressed RNA-binding protein, has been linked to a variety of cellular processes, such as RNA metabolism, microRNA biogenesis and DNA repair. However, the precise role of FUS
Ruepp, Marc-David
core
ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules [PDF]
Mutations in the gene encoding Fused in Sarcoma (FUS) cause amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder. FUS is a predominantly nuclear DNA- and RNA-binding protein that is involved in RNA processing.
Miller, CC +40 more
core +1 more source
Background and Aim: Ewing family of tumors (EFT) encompass a group of small blue round cell tumors, including Ewing sarcoma (ES) and EWSR1-negative undifferentiated small round cell sarcoma.
Mukund N. Sable +2 more
doaj +1 more source
Background Mutations in the gene encoding the RNA-binding protein fused in sarcoma (FUS) can cause familial and sporadic amyotrophic lateral sclerosis (ALS) and rarely frontotemproal dementia (FTD).
Verbeeck Christophe +10 more
doaj +1 more source
Abstract FUS mutations are one of the major mutations in familial amyotrophic lateral sclerosis (ALS). The pathological hallmark is FUS‐positive neuronal cytoplasmic inclusions (FUS‐NCI), known as FUS proteinopathy. Human myxovirus resistance protein 1 (MxA) is an IFN‐induced dynamin‐like GTPase that acts as antiviral factor. In this study, we examined
Hiroyuki Honda +6 more
wiley +1 more source
Characterization of FUS mutations in amyotrophic lateral sclerosis using RNA-Seq. [PDF]
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease resulting in severe muscle weakness and eventual death by respiratory failure. Although little is known about its pathogenesis, mutations in fused in sarcoma/translated in liposarcoma ...
Marka van Blitterswijk +9 more
doaj +1 more source
Unravelling the multiple roles of FUS in RNA processing and on ALS pathogenesis [PDF]
Two genes with related functions in RNA biogenesis were recently reported in patients with familial ALS: the FUS/TLS gene at the ALS6 locus and the TARDBP/TDP-43 gene at the ALS10 locus [1, 2].
Ruepp, Marc-David
core
Exogenous expression of FUS can rescue the depletion of endogenous FUS to repress exon 7. [PDF]
A) Schematic of the rescue assay. FUS protein was first knocked down by siRNA targeting 3′ UTR of FUS for 48 h and then increased by the expression of EGFP-FUS plasmid for 24 h in HEK293 cells. B) Western blot analysis of FUS in the rescue assay.
Geoffrey G. Hicks (14105) +4 more
core +1 more source

